Edition:
United Kingdom

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

123.91USD
19 Jan 2018
Change (% chg)

$2.19 (+1.80%)
Prev Close
$121.72
Open
$122.05
Day's High
$124.05
Day's Low
$121.99
Volume
469,423
Avg. Vol
370,679
52-wk High
$124.05
52-wk Low
$86.55

Chart for

About

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan... (more)

Overall

Beta: 0.49
Market Cap(Mil.): $23,535.67
Shares Outstanding(Mil.): 211.16
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 149.38 16.58
EPS (TTM): -- -- --
ROI: -- 9.44 10.60
ROE: -- 14.87 14.19

BRIEF-Edwards Lifesciences Corp Acquires Harpoon Medical

* EDWARDS LIFESCIENCES CORP - EDWARDS PAID $100 MILLION IN CASH FOR HARPOON AT CLOSING ON DEC. 1

06 Dec 2017

Edwards results fall short of Street estimates; shares tumble

Edwards Lifesciences Corp on Tuesday reported slightly lower-than-expected third-quarter profit and revenue and saw a dip in sales of its critically important transcatheter heart valves from the prior quarter, although they grew about 17 percent from a year earlier.

24 Oct 2017

UPDATE 1-Edwards results fall short of Street estimates; shares tumble

Oct 24 Edwards Lifesciences Corp on Tuesday reported slightly lower-than-expected third-quarter profit and revenue and saw a dip in sales of its critically important transcatheter heart valves from the prior quarter, although they grew about 17 percent from a year earlier.

24 Oct 2017

Edwards 3rd-quarter results short of Street estimates; shares fall

Oct 24 Edwards Lifesciences Corp on Tuesday reported slightly lower-than-expected third-quarter profit and revenue and saw a dip in sales of its critically important transcatheter heart valves from the prior quarter, although they grew about 17 percent from a year earlier.

24 Oct 2017

Edwards Lifesciences raises 2017 forecast after strong quarter

Edwards Lifesciences Corp on Wednesday provided a revised full-year earnings forecast with the new low end of the range above Wall Street estimates, and it posted higher-than-expected second-quarter profit on double-digit growth in sales of its transcatheter heart valves.

26 Jul 2017

UPDATE 2-Edwards Lifesciences raises 2017 forecast after strong quarter

July 26 Edwards Lifesciences Corp on Wednesday provided a revised full-year earnings forecast with the new low end of the range above Wall Street estimates, and it posted higher-than-expected second-quarter profit on double-digit growth in sales of its transcatheter heart valves.

26 Jul 2017

Edwards Lifesciences raises 2017 forecast after strong quarter

July 26 Edwards Lifesciences Corp on Wednesday provided a revised full-year earnings forecast with the new low end of the range above Wall Street estimates, and it posted higher-than-expected second-quarter profit on double-digit growth in sales of its transcatheter heart valve replacements.

26 Jul 2017

Earnings vs. Estimates